Related Experiment Video
Updated: Sep 27, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
HISTOLOGICAL AND HISTOCHEMICAL FEATURES OF LIVER AND LUNG TISSUE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND
O Hryniuk1, O Khukhlina1, I Davydenko2
1Bukovinian State Medical University, Chernivtsi, 1Department of Internal Medicine, Clinical Pharmacology and Occupational Diseases; Chernivtsi, Ukraine.
Abstract:
Objective - to establish the pathomorphological features of liver and lung tissue of patients with non-alcoholic steatohepatitis (NASH) and obesity depending on comorbidity with chronic obstructive pulmonary disease (COPD). The study used autopsy material of 13 cases of NASH and class I obesity (Group 1), 14 cases of NASH, class I obesity with comorbid COPD of stage II-III (Group 2). For comparison, we used the autopsy material of 12 patients with isolated COPD of stage II-III (Group 3), as well as 11 practically healthy individuals (PHI), whose death was caused by polytrauma or traumatic brain injury or sudden coronary death. The groups were randomized by age, sex, and class of obesity. The average age of patients was 59.3±3.21. In Group 2 there was a maximum percentage of hepatocytes in the state of steatosis (1.9 times more than in Group 1, p<0.05), 1.6 times more hepatocytes in the state of fatty necrosis compared with NASH, p<0.05), oncosis (2.1 times, p<0.05), as well as lipofuscinosis (3.1 times more than in case of NASH with obesity, p<0.05). The combined course of obesity, NASH and COPD contributed to a significant increase in the number of lipocytes in the lungs (29.6 times, p<0.05) compared with isolated COPD, as well as a probable increase in their diameter (1.8 times, p<0.05). In the comorbid course of NASH, obesity and COPD, more intense histological and histochemical changes were observed, indicating more significant dysmetabolic disorders and the role of COPD in the activity of the inflammatory process in the liver, namely a higher % of steatosis in hepatocytes. Accumulation of adipocytes was observed in the lungs in this combined pathology, which probably indicates the aggravating effect of NASH and obesity on the course of COPD.
Related Concept Videos
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Chronic Obstructive Pulmonary Disease-I: Introduction

